The Chief Information Officer of the Novartis Institutes for BioMedical Research discusses his new role.

Three-dimensional clusters of human neurons could allow scientists to watch neurological diseases develop in the lab.

At Novartis, we are constantly pushing the limits of science to develop and deliver transformative medicines that fight disease and help people live life on their terms. 

A lung cancer researcher describes her journey toward a career in science at Novartis.

A global survey revealed major disconnects in communication, disease awareness and expectations between patients and physicians.

Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to address high death rates from stroke and heart disease.

Novartis researchers aim to improve the lives of patients with osteoarthritis.

Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.